Macular Degeneration

Offers information on macular degeneration, or AMD, and also how to stop age related macular degeneration.

Entries Tagged ‘Retina’

Macular Degeneration Treatment

Treating Macular Degeneration
There are two treatable types of age related macular degeneration. The most common type is called age related macular degeneration or AMD.  The second type is called wet macular degeneration, and it comprises a much smaller percentage of the cases.  Since wet macular degeneration involves the formation of new blood [...]

Dry Macular Degeneration or Wet Macular Degeneration?

Dry Macular Degeneration or Wet Macular Degeneration?
What is the difference?
Learn how to stop macular degeneration.
Macular degeneration is a disease that afflicts millions of Americans.  Macular Degeneration comes in a number of forms.  The genetic forms are the worst forms because the onset of the disease begins in youth or in the first couple of decades [...]

What Is Macular Degeneration

Macular Degeneration:
Causes, Prevention, & Treatment

Looking for Macular Degeneration Treatment?  Then click here now.

The human eye is a very complex and highly evolved organ.  Humans are able to see when light rays enter the eye through the pupil.  These light rays are received by sophisticated nerves on the surface of the back of the eye [...]

Mechanism that helps us see in bright and low light discovered

WASHINGTON – Vision scientists at Washington University School of Medicine in St. Louis have found an intricate process that allows the human eye to adapt to darkness very quickly. The discovery could contribute to better understanding of human diseases that affect the retina, including age-related macular degeneration. Age-related macular degeneration may be modulated, perhaps, through this pathway [...]

Macuclear and Mystic announce groundbreaking results from Phase Ib Clinical Trial for Macular Degeneration

MacuCLEAR, Inc. and Mystic Pharmaceuticals, Inc., announced today preliminary successful results of a Phase Ib Clinical Trial for the treatment and prevention of the progression of Age Related Macular Degeneration (AMD). The preliminary results indicated that MacuCLEAR’s MC-1101 drug is safe and well tolerated by study participants, and has a biological effect on blood flow in the back of the retina.